BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 25, 2004
 |  BioCentury  |  Strategy

Lightening the load

For the third time in as many years, CuraGen Corp. has announced plans to restructure and refocus its activities in order to continue its transition to product development. The plan is to concentrate resources on moving its most advanced products through the clinic while relying on its mature genomics-based discovery engine to fill out the pipeline.

As CMO and Executive Vice President of R&D Timothy Shannon sees it, the multiple workforce reductions have not occurred as a result of any failures at CuraGen (CRGN, New Haven, Conn.). To the contrary, he argued, the cuts reflect the company's stepwise evolution towards sustainability. "We've done just...

Read the full 504 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >